About Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency
Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency is a rare disease catalogued by Orphanet (ORPHA:319558). It is associated with the IL12B gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency trials.
Search ClinicalTrials.gov for "Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency" or filter by Orphanet code ORPHA:319558 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency. Updated daily.